Drug Shortage Report for JAMP-AMLODIPINE
Report ID | 3489 |
Drug Identification Number | 02357186 |
Brand name | JAMP-AMLODIPINE |
Common or Proper name | Amlodipine besilate |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | AMLODIPINE |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-03-01 |
Estimated end date | |
Actual end date | 2021-04-21 |
Shortage status | Resolved |
Updated date | 2021-07-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.